Topchoice Medical Co., Inc. (SHA:600763)
China
· Delayed Price · Currency is CNY 40.13
+0.14 (0.35%)
Apr 30, 2025, 3:00 PM CST
Topchoice Medical Co. Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Net Income | 582.91 | 572.13 | 500.47 | 548.27 | 702.81 | 492.63 | Upgrade
|
| Depreciation & Amortization | 203.41 | 203.41 | 188.82 | 173.31 | 153.8 | 62.65 | Upgrade
|
| Other Amortization | 64.45 | 64.45 | 55.79 | 46.1 | 35 | 30.22 | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.14 | -0.14 | - | 0.05 | 0.02 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | -0.71 | -0.71 | 0.42 | 0.51 | 0.21 | 0.34 | Upgrade
|
| Loss (Gain) From Sale of Investments | -46.43 | -46.43 | -60.19 | -38.3 | -56.13 | -38.86 | Upgrade
|
| Provision & Write-off of Bad Debts | - | - | 1.75 | 1.67 | 1.29 | 0.47 | Upgrade
|
| Other Operating Activities | 54.06 | 46.77 | 131.85 | 117.71 | 109.25 | 71.83 | Upgrade
|
| Change in Accounts Receivable | -28.94 | -28.94 | -37.49 | -45.07 | -46.88 | -4.27 | Upgrade
|
| Change in Inventory | -3.74 | -3.74 | -1.9 | -2.55 | -2.68 | -1.27 | Upgrade
|
| Change in Accounts Payable | -37.3 | -37.3 | 69.82 | -122.12 | 36.97 | 90.84 | Upgrade
|
| Change in Other Net Operating Assets | -1.64 | -1.64 | -1.64 | -1.64 | -1.64 | -1.64 | Upgrade
|
| Operating Cash Flow | 781.48 | 763.41 | 839.95 | 670.05 | 939.41 | 708.5 | Upgrade
|
| Operating Cash Flow Growth | -3.98% | -9.11% | 25.36% | -28.67% | 32.59% | 7.52% | Upgrade
|
| Capital Expenditures | -265.87 | -332.11 | -505.45 | -421.53 | -367.32 | -170.49 | Upgrade
|
| Sale of Property, Plant & Equipment | 2.03 | 2.02 | 0.01 | 0.62 | 0.02 | 4.69 | Upgrade
|
| Cash Acquisitions | -16.78 | -27.73 | - | - | - | -65.37 | Upgrade
|
| Divestitures | - | - | -0.03 | - | 131.95 | - | Upgrade
|
| Investment in Securities | 13.11 | -7.04 | -504.25 | -60.45 | -234.42 | 13.71 | Upgrade
|
| Other Investing Activities | 28.1 | 39.89 | -14.47 | -15.99 | -14 | -77.03 | Upgrade
|
| Investing Cash Flow | -239.41 | -324.97 | -884.18 | -497.35 | -483.77 | -294.49 | Upgrade
|
| Long-Term Debt Issued | - | 80 | 280 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | - | -118.8 | -193.57 | -251.18 | -241.76 | -95 | Upgrade
|
| Net Debt Issued (Repaid) | -90 | -38.8 | 86.43 | -251.18 | -241.76 | -95 | Upgrade
|
| Repurchase of Common Stock | - | - | -1 | -99.99 | - | - | Upgrade
|
| Common Dividends Paid | -148.68 | -149.89 | -11.24 | -6.69 | -12.87 | -21.08 | Upgrade
|
| Other Financing Activities | -216.3 | -224 | -65.43 | -28.33 | -31.3 | -120.03 | Upgrade
|
| Financing Cash Flow | -454.99 | -412.69 | 8.76 | -386.19 | -285.93 | -236.11 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | - | - | - | - | -0 | Upgrade
|
| Net Cash Flow | 87.08 | 25.75 | -35.47 | -213.5 | 169.71 | 177.9 | Upgrade
|
| Free Cash Flow | 515.61 | 431.3 | 334.5 | 248.52 | 572.09 | 538.01 | Upgrade
|
| Free Cash Flow Growth | 78.12% | 28.94% | 34.60% | -56.56% | 6.33% | 1.25% | Upgrade
|
| Free Cash Flow Margin | 17.72% | 15.01% | 11.75% | 9.14% | 20.57% | 25.77% | Upgrade
|
| Free Cash Flow Per Share | 1.15 | 0.96 | 0.75 | 0.55 | 1.27 | 1.20 | Upgrade
|
| Cash Income Tax Paid | 162.07 | 162.07 | 142.48 | 227.01 | 105.67 | 105.05 | Upgrade
|
| Levered Free Cash Flow | 502.45 | 365.76 | 334.03 | -199.6 | 365.3 | 484.05 | Upgrade
|
| Unlevered Free Cash Flow | 502.45 | 365.76 | 368.41 | -168.32 | 383.37 | 495.77 | Upgrade
|
| Change in Net Working Capital | -55.56 | 7.67 | -195.27 | 425.55 | 18.96 | -166.93 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.